Long-term outcomes of lung transplant with ex vivo lung perfusion

C Divithotawela, M Cypel, T Martinu, LG Singer… - JAMA …, 2019 - jamanetwork.com
Importance The mortality rate for individuals on the wait list for lung transplant is 15% to 25%,
and still only 20% of lungs from multiorgan donors are used for lung transplant. The lung …

Successful treatment of cytomegalovirus associated hemophagocytic lymphohistiocytosis with the interleukin 1 inhibitor–anakinra

C Divithotawela, P Garrett, G Westall… - Respirology case …, 2016 - Wiley Online Library
Hemophagocytic lymphohistiocytosis ( HLH ) is a rare, frequently under‐recognized condition
associated with multi‐organ failure and very high mortality. A 44‐year‐old woman was …

[HTML][HTML] Single-Cell Profiling of Cells in the Lung of a Patient with Chronic Hypersensitivity Pneumonitis Reveals Inflammatory Niche with Abundant CD39+ T Cells …

…, J Voisey, K Spann, M Tan, C Divithotawela… - International Journal of …, 2023 - mdpi.com
… receptors (FcR) for 15 min at 4 C. Cells were washed with MB and resuspended in an
antibody master mix to surface antigens for 30 min at 4 C. The antibody master mix included anti-…

Pulmonary alveolar proteinosis after lung transplantation

C Divithotawela, SH Apte, ME Tan… - Respirology Case …, 2020 - Wiley Online Library
We report the case of a 69‐year‐old man five‐month post double lung transplant for idiopathic
pulmonary fibrosis (IPF) who presented with progressive breathlessness, loss of lung …

Inferior outcomes in lung transplant recipients with serum Pseudomonas aeruginosa specific cloaking antibodies

C Divithotawela, A Pham, PT Bell, EL Ledger… - The Journal of Heart and …, 2021 - Elsevier
Background Chronic Lung Allograft Dysfunction (CLAD) limits long-term survival following
lung transplantation. Colonization of the allograft by Pseudomonas aeruginosa is associated …

Combined heart-lung-liver transplantation for patients with cystic fibrosis: the Australian experience

PT Bell, A Carew, A Fiene, C Divithotawela… - Transplantation …, 2021 - Elsevier
Background Combined multivisceral transplantation has emerged as a therapeutic option
for a select patient cohort; however, clinical decision-making remains complex and …

[HTML][HTML] Erratic tacrolimus levels at 6 to 12 months post-lung transplant predicts poor outcomes

…, T Leisfield, L Winks, DC Chambers, C Divithotawela - JHLT Open, 2024 - Elsevier
Background It has previously been described that erratic tacrolimus blood levels are associated
with graft failure in kidney and liver transplantation. Using a small cohort, we previously …

Pregnancy after lung transplant: case report

C Divithotawela, D Chambers, P Hopkins - Breathe, 2015 - Eur Respiratory Soc
… Other drugs such as voriconazole (FDA category D: evidence of fetal risk), valganciclovir (FDA
category C: fetal risk cannot be ruled out) and ganciclovir (FDA category C) should be …

Should All Donors Be Treated by Ex Vivo Lung Perfusion?—Reply

JM Tikkanen, C Divithotawela, M Cypel - JAMA surgery, 2020 - jamanetwork.com
… We congratulate Divithotawela et al1 for this excellent study. In our … Divithotawela et al1
showed a large volume series that … -treated donor lungs in the Divithotawela et al study1 are the …

Progressive Fibrosing Interstitial Lung Disease in the Real World: A Retrospective Analysis of the Queensland Statewide Interstitial Lung Disease Multi-Disciplinary …

…, C Watters, S Bancroft, C Divithotawela… - … AND PROGNOSIS OF …, 2021 - atsjournals.org
Introduction: Progressive-fibrosing interstitial lung disease (PF-ILD) is attracting increasing
attention as a diagnostic/phenotypic entity. The aim of this study was to describe the …